Posts in Pubblicazioni
- Home
- Category "Pubblicazioni"
- (Page 2)
Regulation of expression of O6-methylguanine-DNA methyltransferase and the treatment of glioblastoma (Review).
Posted on 23 luglio 2015
Regulation of expression of O6-methylguanine-DNA methyltransferase and the treatment of glioblastoma (Review). Cabrini G, Fabbri E, Lo Nigro C, Dechecchi MC, Gambari R. Int J Oncol. 2015 May 29. doi: 10.3892/ijo.2015.3026. Abstract O-6-methylguanine-DNA methyltransferase (MGMT) is an abundantly expressed nuclear protein dealkylating O6-methylguanine (O6-MG) DNA residue, thus correcting the mismatches of O6-MG with a thymine […]
The effect of Paclitaxel and Nab-Paclitaxel in combination with anti-angiogenic therapy in breast cancer cell lines
Posted on 3 giugno 2015
Tonissi F, Lattanzio L, Merlano MC, Infante L, Lo Nigro C, Garrone O.
Invest New Drugs 2015 May 7
The cisplatin-irradiation combination suggests that apoptosis is not a major determinant of clonogenic death.
Posted on 17 dicembre 2014
Lo Nigro C, Arnolfo E, Taricco E, Fruttero A, Russi EG, Lucio F, Ribero S, Comino A, Merlano M, Ungari S.
Anticancer Drugs. 2007 Jul;18(6):659-67.
Supra-additive antitumor effect of sunitinib malate (SU11248, Sutent) combined with docetaxel. A new therapeutic perspective in hormone refractory prostate cancer.
Guérin O, Formento P, Lo Nigro C, Hofman P, Fischel JL, Etienne-Grimaldi MC, Merlano M, Ferrero JM, Milano G.
J Cancer Res Clin Oncol. 2008 Jan;134(1):51-7. Epub 2007 Jun 26.
The combination of docetaxel and the somatostatin analogue lanreotide on androgen-independent docetaxel-resistant prostate cancer: experimental data.
Lo Nigro C, Maffi M, Fischel JL, Formento P, Milano G, Merlano M.
BJU Int. 2008 Aug 5;102(5):622-7. doi: 10.1111/j.1464-410X.2008.07706.x. Epub 2008 May 20.
Impact of erythropoietin on the effects of irradiation under hypoxia
Impact of erythropoietin on the effects of irradiation under hypoxia
Lo Nigro C, Maffi M, Fischel JL, Monteverde M, Catarsi P, Tonissi F, Lattanzio L, Riba M, Etienne-Grimaldi MC, Formento P, Milano G, Merlano M.
J Cancer Res Clin Oncol. 2009 Nov;135(11):1615-23. doi: 10.1007/s00432-009-0609-1. Epub 2009 Jun 5.
Epigenetic downregulation of human disabled homolog 2 switches TGF-beta from a tumor suppressor to a tumor promoter.
Epigenetic downregulation of human disabled homolog 2 switches TGF-beta from a tumor suppressor to a tumor promoter. Hannigan A, Smith P, Kalna G, Lo Nigro C, Orange C, O’Brien DI, Shah R, Syed N, Spender LC, Herrera B, Thurlow JK, Lattanzio L, Monteverde M, Maurer ME, Buffa FM, Mann J, Chu DC, West CM, Patridge […]
Cisplatin-based chemoradiation plus cetuximab in locally advanced head and neck cancer: a phase II clinical study.
Cisplatin-based chemoradiation plus cetuximab in locally advanced head and neck cancer: a phase II clinical study. Merlano M, Russi E, Benasso M, Corvò R, Colantonio I, Vigna-Taglianti R, Vigo V, Bacigalupo A, Numico G, Crosetto N, Gasco M, Lo Nigro C, Vitiello R, Violante S, Garrone O. Ann Oncol. 2011 Mar;22(3):712-7. doi: 10.1093/annonc/mdq412. Epub 2010 […]
Loss of reelin expression in breast cancer is epigenetically controlled and associated with poor prognosis.
Stein T, Cosimo E, Yu X, Smith PR, Simon R, Cottrell L, Pringle MA, Bell AK, Lattanzio L, Sauter G, Lo Nigro C, Crook T, Machesky LM, Gusterson BA.
Am J Pathol. 2010 Nov;177(5):2323-33. doi: 10.2353/ajpath.2010.100209. Epub 2010 Sep 16.
Expression profiling and long lasting responses to chemotherapy in metastatic gastric cancer.
Expression profiling and long lasting responses to chemotherapy in metastatic gastric cancer.
Lo Nigro C, Monteverde M, Riba M, Lattanzio L, Tonissi F, Garrone O, Heouaine A, Gallo F, Ceppi M, Borghi F, Comino A, Merlano M.
Int J Oncol. 2010 Nov;37(5):1219-28.